These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 10875465)
1. Micronutrient antioxidants in gastric mucosa and serum in patients with gastritis and gastric ulcer: does Helicobacter pylori infection affect the mucosal levels? Nair S; Norkus EP; Hertan H; Pitchumoni CS J Clin Gastroenterol; 2000 Jun; 30(4):381-5. PubMed ID: 10875465 [TBL] [Abstract][Full Text] [Related]
2. Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer. Aydemir SA; Tekin IO; Numanoglu G; Borazan A; Ustundag Y Mediators Inflamm; 2004 Dec; 13(5-6):369-72. PubMed ID: 15770055 [TBL] [Abstract][Full Text] [Related]
3. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori. Mehmet N; Refik M; Harputluoglu M; Ersoy Y; Aydin NE; Yildirim B New Microbiol; 2004 Apr; 27(2):139-48. PubMed ID: 15164624 [TBL] [Abstract][Full Text] [Related]
4. Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease. Suzuki H; Mori M; Sakaguchi AA; Suzuki M; Miura S; Ishii H J Gastroenterol Hepatol; 1998 May; 13(5):516-20. PubMed ID: 9641651 [TBL] [Abstract][Full Text] [Related]
6. Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. Koussoulas V; Vassiliou S; Spyridaki E; Demonakou M; Vaki I; Barbatzas C; Giamarellou H; Giamarellos-Bourboulis EJ World J Gastroenterol; 2007 Sep; 13(34):4610-4. PubMed ID: 17729416 [TBL] [Abstract][Full Text] [Related]
7. Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection. Zub-Pokrowiecka A; Rembiasz K; Konturek SJ; Budzynski A; Konturek PC; Budzynski P Med Sci Monit; 2010 Oct; 16(10):CR493-500. PubMed ID: 20885354 [TBL] [Abstract][Full Text] [Related]
8. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Hudson N; Balsitis M; Filipowicz F; Hawkey CJ Gut; 1993 Jun; 34(6):748-51. PubMed ID: 8314505 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia. Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication. Wong BC; Wang WP; So WH; Shin VY; Wong WM; Fung FM; Liu ES; Hiu WM; Lam SK; Cho CH Aliment Pharmacol Ther; 2001 Sep; 15(9):1459-65. PubMed ID: 11552919 [TBL] [Abstract][Full Text] [Related]
11. Gastric alpha-tocopherol and beta-carotene concentrations in association with Helicobacter pylori infection. Zhang ZW; Patchett SE; Perrett D; Domizio P; Farthing MJ Eur J Gastroenterol Hepatol; 2000 May; 12(5):497-503. PubMed ID: 10833091 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Ando T; Kusugami K; Ohsuga M; Shinoda M; Sakakibara M; Saito H; Fukatsu A; Ichiyama S; Ohta M Am J Gastroenterol; 1996 Jun; 91(6):1150-6. PubMed ID: 8651162 [TBL] [Abstract][Full Text] [Related]
13. Topographic expression of MUC5AC and MUC6 in the gastric mucosa infected by Helicobacter pylori and in associated diseases. Marques T; David L; Reis C; Nogueira A Pathol Res Pract; 2005; 201(10):665-72. PubMed ID: 16325508 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa. Mao W; Chen J; Peng TL; Yin XF; Chen LZ; Chen MH Turk J Gastroenterol; 2012 Jun; 23(3):212-9. PubMed ID: 22798109 [TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication. Drake IM; Mapstone NP; Schorah CJ; White KL; Chalmers DM; Dixon MF; Axon AT Gut; 1998 Jun; 42(6):768-71. PubMed ID: 9691912 [TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori HP(2-20) induces eosinophil activation and accumulation in superficial gastric mucosa and stimulates VEGF-alpha and TGF-beta release by interacting with formyl-peptide receptors. Prevete N; Rossi FW; Rivellese F; Lamacchia D; Pelosi C; Lobasso A; Necchi V; Solcia E; Fiocca R; Ceppa P; Staibano S; Mascolo M; D'Argenio G; Romano M; Ricci V; Marone G; De Paulis A Int J Immunopathol Pharmacol; 2013; 26(3):647-62. PubMed ID: 24067461 [TBL] [Abstract][Full Text] [Related]
17. Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients. Yamamoto S; Kaneko H; Konagaya T; Mori S; Kotera H; Hayakawa T; Yamaguchi C; Uruma M; Kusugami K; Mitsuma T Helicobacter; 2001 Jun; 6(2):136-45. PubMed ID: 11422469 [TBL] [Abstract][Full Text] [Related]
18. Gastric mucosal hepatocyte growth factor in Helicobacter pylori gastritis and peptic ulcer disease. Taha AS; Curry GW; Morton R; Park RH; Beattie AD Am J Gastroenterol; 1996 Jul; 91(7):1407-9. PubMed ID: 8678004 [TBL] [Abstract][Full Text] [Related]